Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons

NeuroImmunoModulation

Volumn 3, Issue 2-3, 1996, Pages 69-75

  Gottschall, Paul E ^a   Deb, Suman ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Astrocytes; Central nervous system; Cytokines; Metalloproteinase; Microglia

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN INJURY; EXTRACELLULAR MATRIX; HUMAN; MICROGLIA; NERVE CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASTROCYTES; CYTOKINES; ENCEPHALITIS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; METALLOENDOPEPTIDASES; MICROGLIA; NERVOUS SYSTEM DISEASES; NEURONS; RATS;

EID: 0029829594     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097229     Document Type: Article

References (57)

1. Letoumcau PC, Condic ML, Snow DM: Interactions of developing neurons with the extracellular matrix. J Neurosci 1994:14:915-928.
2. Bignami A, Hosley M, Dahl D: Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol 1994; 188:419-433.
3. Celio MR, Blumeke I: Perineuronal nets -A specialized form of extracellular matrix in the adult nervous system. Brain Res Rev 1994; 19: 128-145.
4. Yamada H, Watanabc K, Shimonaka M, Ya-maguchi Y: Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versi-can family. J Biol Chem 1994:269:10119-10126.
5. hvata M, Carlson SS: A large chondroitin sulfate proteoglycan has the characteristics of a general extracellular matrix component of adult brain. J Neurosci 1993;13:195-207.
6. Brodkey JA, Laywcll ED, O’Brien TF, Faissner A, Stefansson K, Dorries HU, Schachner M, Steindler DA: Focal brain injury and upregula-tion of a developmental regulated extracellular matrix protein. J Neurosurg 1995:82:106-112.
7. Horwitz AF, Theiry JP: Cell-to-ccli contact and extracellular matrix. Curr Opin Cell Biol 1994; 6:645-647.
8. Webersinke G, Bauer H, Amberger A, Zach O, Bauer HC: Comparison of gene expression of extracellular matrix molecules in brain micro-vascular endothelial cells and astrocytes. Bio-chem Biophvs Res Commun 1992; 189:877-884.
9. Pasinctti GM, Nichols NR. Tocco G, Morgan T, Laping N, Finch CE: Transforming growlh factor β1 and fibronectin messenger RNA in rat brain: Responses to injury and cell-type localization. Neuroscience 1993;54:893-907.
10. Martin U, Pardo CA, Cork LC, Price DL: Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 1994; 145:1358-1381.
11. Snow AD, Mar H, Nochlin D, Kimatas K, Kato M, Suzuki S, Hassell J, Wight T: The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 1988; 133:456-463.
12. Perlmutter LS, Barron E, Saperia D, Chui HC: Association between vascular basement membrane components and the lesions of Alzheimer’s disease. J Neurosci Res 1991;30:673-681.
13. Su JH, Cummings BJ, Colman CW: Localization of heparan sulfate gfycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 1992;51: 801-813.
14. Snow AD, Wight TN: Proteoglycans in the pathogenesis of AD and other amyloidoses. Neurobiol Aging 1989;10:481-487.
15. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K: Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 1994;144:337-347.
16. Snow AD, Kinsclla MG, Parks E, Sekiguchi RT, Miller JD, Kimata K, Wight TN: Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versi-can) to the beta-amyloid protein of Alzheimer's disease. Arch Biochem Biophys 1995:320:84-95.
17. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG: An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar A alpha-amyloid in rat brain. Neuron 1994; 12: 219-234.
18. Juckcr M, Walker LC, Kibbey MC, Kleinman HK, Ingram DK: Localization of a laminin binding protein in brain. Neuroscience 1993; 56:1009-1022.
19. Kibbey MC, Jucker M, Weeks BS, Neve RL, Van Nostrand WE, Kleinman HK: β-Amyloid precursor protein binds to the ncuritc-promot-ing IKVAV site of laminin. Proc Natl Acad Sci 1993:90:10150-10153.
20. Narindrasorasak S, Lowery DE, Allman RA, Gonzalezdewhitt PA, Greenberg BD, Kisilcv-sky R: Characterization of high affinity binding between laminin and Alzheimer’s disease amyloid precursor proteins. Lab Invest 1992;67: 643-652.
21. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L: Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice ovcrcxpressing transforming growth faclor-β1. Am J Pathol 1995;147:53-67.
22. Rogers SL, Cutts JL, Gegick PJ, Mcguire PG, Rosenberger C, Krisinski S: Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines. Exp Cell Res 1994; 211:252-262.
23. Pclion RW, Saxena B, Jones M, Moses HL, Gold LI: Immunohistochemical localization of TGF-pl, TGF-P2 and TGF-P3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991;115:1091-1105.
24. Van der Wal EA, Gomez-Pinilla F, Cotman CW: Transforming growth factor-pi is in plaques in Alzheimer and Down pathologies. Neuroreporl 1993;4:69-72.
25. Lotan M, Schwartz M: Cross talk between the immune system and the nervous system in response to injury: Implications for regeneration. FASEBJ 1994;8:1026-1033.
26. Wocssner JFJ: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEBJ 1991;5:2145-2154.
27. Birkedal-Hanson H, Moore WGI, Boddcn MK, Windsor LJ, Birkedal-Hanson B, DeCarlo A, Engler JA: Matrix metalloproteinases; A review. Crit Rev Oral Biol Med 1993:4:197-250.
28. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metallopro-teinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-65.
29. Krystosek A, Seeds NW: Plasminogen activator secretion by granule neurons in cultures of developing cerebellum. Science 1981:213: 7810-7814.
30. Pittman RN: Release of plasminogen activator and a calcium-dependent metalloprotease from cultured sympathetic and sensor neurons. Dev Biol 1985;110:91-101.
31. ++-dependent metalloproteinasc activity. Dev Neurosci 1988; 11:41-51.
32. Pascal-Sappino A. Madani R. Huartc J. Bclin D, Kiss JZ, Wohhvend A, Vassalli J-D: Extracellular proteolysis in the adult murine brain. J Clin Invest 1993;92:679-685.
33. Nelson RB, Siman R: Identification and characterization of calcium-dependent mctallopro-teascs in rat brain. J Neurochem 1989;53:641-647.
34. Nordstrom LA, Lochner J, Yeung W, Ciment G: The metalloproleinase stromelysin-l (transin) mediates PC12 cell growth invasivencss through basal laminae. Mol Cell Neurosci 1995;6:56-68.
35. Muir D: Metalloproteinase-depcndent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 1994;210:243-252.
36. Backstrom JR, Tokes ZA: The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. J Neurochem 1995;64: 1312-1318.
37. Rosenberg GA, Dencoff JE, Mcguire PG, Liot-ta LA, Stetler-Stevenson WG: Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 1994;71:417-422.
38. Gijbels K, Masure S, Carton H, Opdenakker G: Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 1992; 41:29-34.
39. Gijbels K, Proost P, Masuure S, Carton H, Bil-liau A, Opendakker G: Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 1993;36: 432-440.
40. Giraudon P, Thomasset N, Bernard A, Verrir B, Belin MF: Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of mctalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-1. Eur J Neurosci 1995;7: 841-848.
41. Eddleston M, Muekc L: Molecular profile of reactive astrocytes -implications for their role in neurologic disease. Neuroscience 1993:54: 15-36.
42. Backstrom JR, Miller CA, Tokes ZA: Characterization of neutral prolcinases from Alzhci-mcr-affcclcd and control brain specimens: Identification of calcium-dependent mctallo-proteinascs from the hippocampus. J Neuro-chem 1992:58:983-992.
43. Yamada T, Miyazaki K, Koshikawa N, Taka-hashi M, Akalsu H, Yamamoto T: Selective localization of gelatinasc A, an enzyme degrading P-amyloid protein, in white matter microglia and Schwann cells. Acta Neuropathol 1995:89:199-203.
44. Peress N, Perillo E, Zucker S: Localization of tissue inhibitor of matrix metalloproteinascs in Alzheimer’s disease and normal brain. J Neu-ropathol Exp Neurol 1995:54:16-22.
45. Bignami A, LeBlanc A, Perides G: A role for extracellular matrix degradation and matrix metalloproteinascs in senile dementia? Acta Neuropathol 1994:87:308-312.
46. Deb S, Gottschall PE: Increased production of matrix mclalloprotcinases in enriched astrocyte and mixed hippocampal cultures treated with p-amyloid peptides. J Neurochem. in press.
47. Mauviel A: Cytokine regulation of metallopro-teinase gene expression. J Cell Biochem 1993; 53:288-295.
48. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKcrrow JH. Banda MJ: Expression of metalloproteinascs and mclalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 1990:50: 2322-2329.
49. Olson JA, Shiverick KT, Ogilvie S, Buht WC, Raizada MK: Angiotensin II induces secretion of plasminogen activator inhibitor I and tissue mctalloprotcasc inhibitor-related protein from rat brain astrocytes. Proc Natl Acad Sci USA 1991:88:1928-1932.
50. Sawava R, Tofilon PJ, Mohanam S, Aliosman F, Liotta LA, Stetler-Slevenson WG, Rao JS: Induction of tissue-type plasminogen activator and 72-kDa type-IV collagcnasc by ionizing radiation in rat astrocytes. Int J Cancer 1994; 56:214-218.
51. Gottschall PE, Yu X: Cytokines regulate gclati-nase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 1995:64:1513-1520.
52. Colton CA, Keri JE, Chen WT, Monsky WL: Protease production by cultured microglia -Substrate gel analysis and immobilized matrix degradation. J Neurosci Res 1993:35:297-304.
53. Gottschall PE, Yu X, Bing B: Increased production of gelatinasc B (matrix mctalloprotein-asc-9) and intcrlcukin-6 by activated microglia inculture. J Neurosci Res 1995;42:335-342.
54. Machida C, Roland K, Matrisian L, Magun B, Ciment G: NGF induction of the gene encoding theprotcase transin accompanies neuronal differentiation in PC12 cells. Neuron 1989:2: 1587-1596.
55. Machida CM, Scot JD, Ciment G: NGF-induc-tion of the metalloproteinase transin/slromely-s in in PCI2 cells: Involvement of multiple protein kinases. J Cell Biol 1991.114:1037-1048.
56. Fillmore HL, Mainardi CL, Hasty KA: Differentiation of PCI 2 cells with nerve growth factor is associated with induction of transin synthesis and rclcisc. J Neurosci Res 1992:31: 662-669.
57. Desouza S, Lochner J, Machida CM, Matrisian LM, Ciment G: A nevcl nerve growth factor-responsive clement in thcstromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PCI2 cells. J Biol Chem 1995; 270:9106-9114.